Synmosa Biopharma Corporation (TPEX: 4114)
Taiwan
· Delayed Price · Currency is TWD 36.85
-0.20 (-0.54%)
Oct 11, 2024, 1:30 PM CST
Synmosa Biopharma Market Cap
Synmosa Biopharma has a market cap or net worth of 15.45 billion as of October 11, 2024. Its market cap has increased by 9.12% in one year.
Market Cap
15.45B
Enterprise Value
17.42B
Revenue
5.19B
Ranking
n/a
PE Ratio
22.57
Stock Price
36.85
Market Cap Chart
Since May 8, 2006, Synmosa Biopharma's market cap has increased from 583.47M to 15.45B, an increase of 2,547.15%. That is a compound annual growth rate of 19.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition